NASDAQ:NEPH

Nephros (NEPH) Stock Forecast, Price & News

$1.61

+0.01 (+0.63%)

(As of 10:40 AM ET)

Compare

Today's Range: $1.42
▼
$1.63
50-Day Range: $1.01
▼
$1.60
52-Week Range: $0.91
▼
$2.02

Volume: 60,932 shs
Average Volume: 48,378 shs
Market Capitalization: $16.87 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Nephros (NASDAQ:NEPH) Stock

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.

Receive NEPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter.

NEPH Stock News Headlines

May 30, 2023 | americanbankingnews.com

Nephros, Inc. (NASDAQ:NEPH) Short Interest Down 13.8% in May

May 24, 2023 | finance.yahoo.com

Nephros to Present at LD Micro Invitational XIII

June 1, 2023 | Edge On The Street (Ad)

AI Getting Close to Thinking Like Humans

Technology experts working with neuroscientists have created the world's first Artificial Intelligence Network Operating System. AI can now process information like the human brain and understand the world the way humans do.

May 13, 2023 | markets.businessinsider.com

Sientra (SIEN) Gets a Buy from Maxim Group

May 12, 2023 | msn.com

Nephros GAAP EPS of -$0.03 misses by $0.01, revenue of $3.7M beats by $0.02M

May 10, 2023 | finance.yahoo.com

Nephros Announces Results for Quarter Ended March 31, 2023

May 9, 2023 | americanbankingnews.com

Nephros (NEPH) Set to Announce Quarterly Earnings on Wednesday

May 8, 2023 | finanznachrichten.de

Nephros, Inc.: Nephros Announces CEO Retirement and Succession Plan

June 1, 2023 | Edge On The Street (Ad)

AI Getting Close to Thinking Like Humans

May 8, 2023 | finance.yahoo.com

Nephros Announces CEO Retirement and Succession Plan

May 3, 2023 | americanbankingnews.com

Head-To-Head Analysis: Nephros (NASDAQ:NEPH) and KORU Medical Systems (NASDAQ:KRMD)

April 26, 2023 | finance.yahoo.com

Nephros Schedules First Quarter 2023 Financial Results Conference Call

April 24, 2023 | marketwatch.com

Dialysis WaterFiltration Market 2023 by Sales, Share, Growth Opportunity with Top Players are Nephros, Evoqua,Culligan, Veolia Water Technologies

April 6, 2023 | benzinga.com

Nephros, Inc. (NEPH) Stock Rises 22.86% This Week; Should You Buy?

April 6, 2023 | markets.businessinsider.com

Nephros (NEPH) Receives a Buy from Maxim Group

April 4, 2023 | msn.com

Nephros Soars after Better-than-Expected Preliminary Q1 Revenues

April 4, 2023 | finanznachrichten.de

Nephros, Inc.: Nephros Announces Preliminary Results for First Quarter 2023

April 4, 2023 | finance.yahoo.com

Nephros Announces Preliminary Results for First Quarter 2023

April 1, 2023 | americanbankingnews.com

Contrasting Nephros (NASDAQ:NEPH) and Treace Medical Concepts (NASDAQ:TMCI)

March 11, 2023 | finance.yahoo.com

Nephros, Inc. (NASDAQ:NEPH) Q4 2022 Earnings Call Transcript

March 10, 2023 | finance.yahoo.com

Nephros Full Year 2022 Earnings: Misses Expectations

March 9, 2023 | finance.yahoo.com

Q4 2022 Nephros Inc Earnings Call

March 9, 2023 | finanznachrichten.de

Nephros, Inc.: Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results

March 8, 2023 | finance.yahoo.com

Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results

March 7, 2023 | msn.com

Nephros's Earnings: A Preview

March 2, 2023 | msn.com

Nephros and Donastar enter new strategic partnership

March 1, 2023 | finance.yahoo.com

Nephros and Donastar Announce Strategic Partnership

See More Headlines

NEPH Price History

30 days | 90 days | 365 days | Advanced Chart

NEPH Company Calendar

Last Earnings: 11/04/2021
Today: 6/01/2023
Next Earnings (Estimated): 8/09/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:NEPH
CUSIP: N/A
CIK: 1196298
Web: www.nephros.com
Phone: (201) 343-5202
Fax: 201-343-5207
Employees: 34
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-7,380,000.00
Net Margins: -47.90%
Pretax Margin: -26.25%
Return on Equity: -30.34%
Return on Assets: -25.07%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 5.88
Quick Ratio: 4.22

Sales & Book Value

Annual Sales: $9.98 million
Price / Sales: 1.61
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.85 per share
Price / Book: 1.80

Miscellaneous

Outstanding Shares: 10,480,000
Free Float: 9,950,000
Market Cap: $16.03 million
Optionable: Not Optionable
Beta: 1.25

Key Executives

Robert Banks
President, Chief Executive Officer & Director

Andrew Astor
Chief Financial Officer

Michael Milman
Vice President-Research & Development

Anthony Robinson
Vice President-Operations

Alfred Vargas
Director-Logistics & Manufacturing

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

NEPH Stock - Frequently Asked Questions

How have NEPH shares performed in 2023?: Nephros' stock was trading at $1.1572 at the beginning of 2023. Since then, NEPH shares have increased by 32.2% and is now trading at $1.53.
View the best growth stocks for 2023 here.
Are investors shorting Nephros?: Nephros saw a drop in short interest in May. As of May 15th, there was short interest totaling 18,100 shares, a drop of 13.8% from the April 30th total of 21,000 shares. Based on an average trading volume of 16,700 shares, the days-to-cover ratio is currently 1.1 days. Currently, 0.2% of the shares of the company are short sold.
View Nephros' Short Interest.
When is Nephros' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023.
View our NEPH earnings forecast.
How were Nephros' earnings last quarter?: Nephros, Inc. (NASDAQ:NEPH) announced its quarterly earnings data on Thursday, November, 4th. The company reported ($0.12) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.12). The business had revenue of $2.64 million for the quarter, compared to analyst estimates of $2.64 million. Nephros had a negative trailing twelve-month return on equity of 30.34% and a negative net margin of 47.90%. During the same period in the prior year, the business posted ($0.12) EPS.
What guidance has Nephros issued on next quarter's earnings?: Nephros issued an update on its first quarter 2023 earnings guidance on Tuesday, April, 4th. The company provided EPS guidance of for the period. The company issued revenue guidance of $3.70 million-$3.70 million, compared to the consensus revenue estimate of $2.68 million.

What is Nephros' stock symbol?: Nephros trades on the NASDAQ under the ticker symbol "NEPH."
Who are Nephros' major shareholders?: Nephros' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Susquehanna International Group LLP (0.34%) and Renaissance Technologies LLC (0.22%). Insiders that own company stock include Andrew Astor, Tom Gwydir and Wesley S Lobo.
View institutional ownership trends.
How do I buy shares of Nephros?: Shares of NEPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Nephros' stock price today?: One share of NEPH stock can currently be purchased for approximately $1.53.
How much money does Nephros make?: Nephros (NASDAQ:NEPH) has a market capitalization of $16.03 million and generates $9.98 million in revenue each year.
How can I contact Nephros?: Nephros' mailing address is 380 LACKAWANNA PLACE, SOUTH ORANGE NJ, 07079. The official website for the company is www.nephros.com. The company can be reached via phone at (201) 343-5202, via email at ksmith@pcgadvisory.com, or via fax at 201-343-5207.

This page (NASDAQ:NEPH) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial